嵌合体监测在非清髓异基因造血干细胞移植后干预治疗中的应用
出处
《临床荟萃》
CAS
2009年第16期1413-1414,共2页
Clinical Focus
参考文献8
-
1Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation [J]. Bio Blood Marrow Transplant,2001,7(9) :473-485.
-
2Storb RF, Champlin R, Riddell SR, et al. Non-myeloablative transplants for malignant disease. Hematology ( 2001 the American Society of Hematology Education Program Book) [M]. Washington: Fred Hutchinson Cancer Center, 2001:375-391.
-
3Dubovsky J, Daxberger W, Fritsch G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders:implications for timely detection of engraftment, graft failure and rejection[J]. Leukemia,1999,13(12) :2059-2069.
-
4De Weger RA, Tilanus MG, Scheidel KC, et al. Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats[J]. Br J Haematol, 2000,110(3): 647-653.
-
5唐晓文,吴德沛,常伟荣,朱子玲,阮长耿.供体细胞嵌合率的动态定量检测在供体淋巴细胞回输中的应用[J].中华肿瘤杂志,2004,26(3):186-187. 被引量:2
-
6Novitzky N, Rubinstein R, Hallett JM, et ah Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphoeytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy [ J ]. Transplantation, 2000,69 (7): 1358-1363.
-
7孙敬芬,韩晓苹,赵丹丹,汪菲菲,靳海杰,高春记,达万明,于力.STR-PCR分析嵌合体在同种异基因造血干细胞移植中的应用[J].中国实验血液学杂志,2007,15(2):337-341. 被引量:10
-
8丁家华,陈宝安,王椿,王健民,孙耘玉,赵刚,高冲,王骏,程坚,董伟民.异基因造血干细胞移植后全血细胞减少的脾切除治疗一例报告并文献复习[J].中华血液学杂志,2004,25(2):123-124. 被引量:3
二级参考文献16
-
1李素霞,达万明,高春记,朱海燕,王书红,薄剑,靖彧,靳海杰.STR-PCR对造血干细胞移植后植入证据的检测[J].中国实验血液学杂志,2005,13(1):25-29. 被引量:6
-
2Nollet F, Billiet J, Selleslag D, et al. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transplant, 2001, 28: 511-518.
-
3Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendation from a workshop at the 2001 Tandem Meeting of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 2001, 7: 473-485.
-
4Spitzer TR, McAfee S, Sackstein R, et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant, 2000, 6: 309-320.
-
5Bader P,Klingebiel T,Schaudt A,et al.Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixedchimerism:a single center experience of 12 children.Leukemia,1999;13:2079-2086
-
6Dubovsky J,Daxberger H,Fritsch G,et al.Kinetics of chimerism during the early post -transplant period in pediatric patients with malignant and non-malignant hematologic disorders:implication for timely detection of engraftment,graft failure and rejection.Leukemia,1999; 13:2059,2060-2069
-
7Thiede C,Florek M,Bornhauser M,et al.Rapid quantification mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescene detection.Bone Marrow Transplant,1999;23:1055-1059
-
8Nollet F,Billiet J,Selleslag D,et al.Standardisation of multiplex fluorescent short tandem repeat analysis for chime-rism testing.Bone Marrow Transplant,2001; 28:511-518
-
9Bader P,Holle W,Klingebiel T,et al.Mixed hematopoietic chimerism after allogeneic bone marrow transplantation:the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.Bone Marrow Transplanat,1997; 19:697 -702
-
10Sykes M.Mixed chimerism and transplant tolerance.Immunity,2001; 14:417 -424
共引文献12
-
1崔晓,刘冠贤,石咏军.建立嵌合体诱导移植免疫耐受的研究进展[J].当代医学,2008,14(14):25-26. 被引量:1
-
2马丽辉,李宝平,刘卓拉,乔振华,张雷,崔月娥,鹿育晋.供体淋巴细胞注射治疗恶性浆膜腔积液的临床研究[J].肿瘤研究与临床,2006,18(1):26-27.
-
3陈宝安,熊辉霞,丁家华,苏恩本,赵刚,王骏,高冲,孙耘玉,程坚.非清髓异基因外周血造血干细胞移植后嵌合体分析[J].中国实验血液学杂志,2006,14(2):313-317. 被引量:6
-
4高峰,王艳玲,朱梦波,崔晓聪,杜小梅,冯术青,李小宇,陈乃耀.ABO血型不合异基因造血干细胞移植治疗慢性粒细胞性白血病1例并文献复习[J].中国综合临床,2007,23(1):26-27.
-
5宁涓,刘启发,罗晓丹,范志平,张钰,孙竞.撤离免疫抑制剂联合白细胞介素2治疗同种异基因造血干细胞移植后白血病复发患者临床疗效观察[J].中华血液学杂志,2008,29(7):480-481. 被引量:2
-
6孙敬芬,赵丹丹,韩晓苹,金红实,于力.异基因造血干细胞移植后复发慢性髓系白血病患者嵌合体和融合基因的动态观察[J].中国实验血液学杂志,2008,16(4):833-837. 被引量:2
-
7张秀华,范雪晖,吴登俊.ABI310遗传分析仪自动检测多重聚合酶链反应扩增短串联重复序列产物及数据分析的应用特征[J].中国组织工程研究与临床康复,2008,12(35):6859-6862.
-
8李娅娜,刘孟黎.输血相关的微嵌合体[J].中国实验血液学杂志,2009,17(1):247-250. 被引量:3
-
9杨凯,陈惠仁,何学鹏,司英健,杜振兰,张小妹.含氟达拉滨预处理方案对异基因造血干细胞移植过程中造血重建、移植物抗宿主病及患者生存的影响[J].中国组织工程研究与临床康复,2009,13(32):6314-6318. 被引量:1
-
10宋闿迪,孙自敏,刘会兰,耿良权,王兴兵,张旭晗,方欣臣,朱薇波,王祖贻.复合扩增荧光标记短串联重复序列技术预测非血缘脐血移植植入规律的研究[J].中华血液学杂志,2010,31(5):341-343. 被引量:2
-
1乔建辉,余长林,王丹红,郭梅,孙万军,孙琪云,艾辉胜.非清髓造血干细胞移植后移植排斥原因初探[J].解放军医学杂志,2002,27(10):927-929. 被引量:2
-
2郭宏锋,乔振华,苏丽萍,马梁明,朱镭,葛晓燕,李蓉萍.非清髓异基因造血干细胞移植后免疫重建的初步研究[J].中华血液学杂志,2003,24(8):433-434. 被引量:3
-
3刘红艳,夏凌辉,郭静明,王海燕,朱磊,刘斌.造血干细胞移植治疗多发性骨髓瘤的研究进展[J].武汉大学学报(医学版),2008,29(2):275-278. 被引量:3
-
4韩方海.胃肠肿瘤的外科治疗和重建[J].中华普通外科学文献(电子版),2010,4(3):1-3. 被引量:11
-
5李宁,王旗,陈萍萍,谢东,崔玲玲,李文杰.肺癌组织中WISP-1 mRNA和蛋白的表达[J].郑州大学学报(医学版),2007,42(5):856-858.
-
6张东华,肖毅,冉丹,李登举,刘文励.非清髓异基因造血干细胞移植治疗有并发症的白血病三例[J].中华血液学杂志,2003,24(8):440-441. 被引量:2
-
7熊辉霞,陈宝安.STR-PCR半定量检测嵌合体方法在非清髓异基因造血干细胞移植中的应用[J].青海医学院学报,2008,29(1):54-57. 被引量:1
-
8徐果,朱德祥.氟尿嘧啶植入剂在进展期胃癌术中应用的临床研究[J].重庆医学,2011,40(4):353-354. 被引量:7
-
9郑秀娟,李淞漪.阿司匹林对宫颈癌Hela细胞COX-2 mRNA表达的抑制作用[J].浙江临床医学,2007,9(11):1461-1462. 被引量:5
-
10罗俊卿,许其稳,王珍亮,宋小军,舒小兰,吴娟,贺凌云.氧化砷对结肠癌细胞增殖的影响[J].武警医学,2004,15(2):110-112.